drug study (agn)
TRANSCRIPT
DRUGS DOUSAGE, ROUTE AND FREQUENCY
ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
GENERIC NAME:Nifedipine
BRAND NAME:
GENERAL CLASSIFICATION:Anti-hypertensives
SPECIFIC CLASSIFICATION:Calcium Channel Blocker
DATE ORDERED:07-29-10
5 mg SL now then q 6
Unknown, though to inhibit calcium ion influx across cardiac and smooth muscle cells, decrease contractility and oxygen demand. Also may dilate coronary artery and arterioles.
Given to our patient to manage hypertension.
To potentiate effectiveness of the drug: Instruct patient to not to crew the med
(soft gel) Advise patient to avoid taking drug with
grapefruit juice Tell patient to protect the capsule from
direct sunlight and moisture and to restore at room temperature
Ensure safe use of the drug: Monitor patient blood pressure Contraindicated to patient with
hypersensitivity to drug Watch for symptoms of heart failure Perform daily weighting and monitor for
swelling Monitor for adverse reaction such as:
1. Dizziness2. Light headedness3. Headache 4. Weakness5. Peripheral edema6. Hypotension7. Palpitation8. Heart failure
DRUGS DOUSAGE, ROUTE AND FREQUENCY
ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
GENERIC NAME:Mupirocin
BRAND NAME:
SPECIFIC CLASSIFICATION:Topical drug
GENERAL CLASSIFICATION:Local anti-infectives
DATE ORDERED:07-29-10
4x AS on LE Unknown, though to inhibit bacterial protein and RNA synthesis
Given to treat infected wounds/ cuts
To potentiate effectiveness of the drug: Clean and dry affected areas before
applying Observe aseptic technique when
applying the drug
Ensure safe use of the drug: Use medication for external only Can cover affected areas with bandage /
gauze Monitor side effects such as:
1. Burn2. Itching3. Stinging
DRUG DOUSAGE, ROUTE AND FREQUENCY
ACTION DESIRED EFECT NURSING RESPONSIBILITIES
GENERIC NAME:Captopril
BRAND NAME:
GENERAL CLASSIFICATION:Anti-hypertensives
SPECIFIC CLASSIFICATION:Angiotensin Converting Enzymes inhibitor
DATE ORDERED:07-30-10
25 mg ½ tab BID OD
Inhibits ACE, preventing conversion of angiotensin I to angiotensin II , a potent vasoconstrictor, less angiotensin II decreases peripheral arterial resistance, decreases aldosterone secretion w/c reduces sodium and water retention and lowers blood pressure
Given to our patient to decrease the blood pressure/ management of hypertension
To potentiate effectiveness of the drug: Instruct to take drug 1 hr before meal
Ensure safe use of the drug: Monitor pt. BP and RR frequently Uses cautiously c pt. c renal/ impaired
renal function Instruct pt/ SO to report: swelling of
face, lips and mouth/ DOB Advise to avoid sudden position change
to minimize hypotension Monitor for protenuria every 2-4 wks for
the first 3 mos of therapy to decrease renal function
Monitor adverse reaction such as:1.dizziness2. fainting3.headache4.malaise/fatigue5.fever6.diarrhea7. dry mouth8. nausea and vomiting9. protenuria
DRUGS DOUSAGE, ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
ROUTE AND FREQUENCY
GENERIC NAME:Furosemide
BRAND NAME:Lasix GENERAL CLASSIFICATION:Loop Diuretics DATE ORDERED:07-29-10
30 mg TIV q 12 c BP precaution < 90/60
Inhibit the reabsorption of sodium and chloride in the proximal and distal tubules as well as the ascending loop of Henle: this result in the excretion of sodium chloride and to a lesser degree, potassium and bicarbonate ions
This drug is given to the patient to treat edema and to prevent hypertension
To potentiate effectiveness of the drug: Performed aseptic technique in
handling and administering of the drugEnsure safe use of the drug:
Check BP before giving med Monitor weight and input and output
for edema Advise patient not to consume
excessive amount of coffee, tea, or cola;may interefere with BP control and drug effectiveness
Encourage to comply with additional antihypertensive intervension such as;weight reduction, low sodium diet, regular exercise and stress management
When given IV give slowly for 1-2 mins Given in the morning Discuss need to increase foods high in
potassium like; Banana,watermelon, Monitor ototoxicity Advise patient to report immediately;
ringing in ears, abdominal pain, sore throat and fever
Instruct patient to report adverse reaction such as:1. Muscle weakness2. Dizziness3. Numbness and tingling4. Blurred vision5. Nausea and vomiting
DRUGS DOUSAGE, ROUTE AND FREQUENCY
ACTION DESIRED EFFECT
NURSING RESPONSIBILITIES
GENERIC NAME:Penicillin G
BRAND NAME:
GENERAL CLASSIFICATION:Antibiotics
DATE/TIME ORDERED:07-29-104:30PM
790000 IU TIV q 6 ANST ( )
Inhibit cell wall synthesis during bacterial multiplication
Given to our patient to treat systemic infection
To potentiate effectiveness of the drug: Ensure skin testing Performed aseptic technique in administering
Ensure safe use of the drug: Administer the drug slow Tell patient to report immediately rash, chills
and fever Use sterile water, isotonic saline in mixing for
desired strength Donot mix with other medications like
aminophylline, ascorbic acid, gentmicyn and heparin
Monitor adverse reaction such as:1. Neuropathy2. Seizures3. Hallucinations4. Agitation5. Confusion6. Dizziness7. Fatigue
DRUG DOUSAGE, ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
ROUTE AND FREQUENCY
GENERIC NAME:Paracetamol
BRAND NAME:
GENERAL CLASSIFICATION:Non-opiod analgesic and antipyretics
DATE ORDERED:08-03-10
500 mg 1 tab/ 250 mg/ 5 ml give 10 ml
Drug may relieve fever through central action in the hypothalamic heat regulating center.
Given to our patient to decrease body temperature
To potentiate effectiveness of the drug: Do handwashing before handling med Performed TSB Use light clothings and provide proper
ventilationEnsure safety of the patient
Use cautiously in pt hypersensitive to drug
Monitor hematologic status because it can decrease RBC,WBC and platelets
Monitor adverse reaction such as:1.Hemolytic Anemia2. Neutropenia3.Leukopenia4. Pancytopenia5. Jaundice6. Hypoglycemia7. rash
DRUG DOUSAGE, ACTION DESIRED NURSING RESPONSIBILITIES
ROUTE AND FREQUENCY
EFFECT
GENERIC NAME:Cefuroxime sodium
BRAND NAME:
GENERAL CLASSIFICATION:Cephalosporin
SPECIFIC CLASSIFICATION:2nd generation cephalosporin DATE/TIME ORDERED:08-08-10
250 mg 7-8 ml 2x a day
Second generation cephalosporin that inhibits cell wall synthesis, thus promoting osmotic instability, usually bactericidal.
Given to our patient to treat systemic infection
To potentiate effectiveness of the drug: Suspension will be given with foods Do hand washing before handling the
medEnsure safe use of the drug
Report signs of anorexia, dizziness, pale skin and SOB
Drug regimen (therapy given for 10 days) Monitor adverse reaction such as:
1. Diarrhea 2. Nausea3. Rash
DRUG DOSAGE, ROUTE AND FREQUENCY
ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
GENERIC NAME:Sumapen
BRAND NAME:
GENERAL CLASSIFICATION:Anti- infectives
DATE ORDERED:08-08-10
500 mg 1 cap 3x a day
Inhibit cell wall synthesis during bacterial multiplication
Given to our patient to treat systemic infection
To potentiate effectiveness of the drug: Taken in an empty stomach Taken 1 hr before / 2 hr after meals
Ensure safe use of the drug: Contraindicated to pt with allergies to
penicillin Use cautiously to patient c renal
impairment Monitor for adverse reactions such as:
1. GI disturbances2. Allergic skin reactions 3. Blood disorders 4. Anaphylaxis5. Black hairy tongue6. Neuropathy
DRUG DOSAGE, ROUTE AND FREQUENCY
ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
GENERIC NAME:Ranitidine
BRAND NAME:Zantac
GENERAL CLASSIFICATION:Anti- ulcer
SPECIFIC CLASSIFICATION:H2 receptor antagonist
DATE ORDERED:08-02-10
25 mg TIV q8 Competitively inhibit action of histamine on the h2 at receptor sites of parietal cells, decreasing gastric acid secretion
Given as a prophylaxis for other drug given such as cefuroxime
To potentiate effectiveness of the drug: Ensure skin testing Aseptic technique in administering med
To ensure safe use of the drug: Avoid food that can increase gastric
secretion such as: coffee, tea, soda and spicy foods
Use cautiously in patient with impaired renal function
Advise to report abdominal pain and blood in stool / emesis
monitor adverse reaction such as:1. vertigo2. malaise3. headache 4. blurred vision5. jaundice
DRUG STUDY